How much revenue did Vita 34 generate this year?
Vita 34 has achieved a revenue of 81.81 M EUR this year.
Vita 34 Revenue 2024
Vita 34 Revenue
81.81 M EUR
Ticker
V3V.DE
ISIN
DE000A0BL849
WKN
A0BL84
In 2024, Vita 34's sales reached 81.81 M EUR, a 6.16% difference from the 77.06 M EUR sales recorded in the previous year.
The Vita 34 Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2027e | 128.03 | 22,16 |
| 2026e | 86.76 | 32,70 |
| 2025e | 84.23 | 33,68 |
| 2024e | 81.81 | 34,68 |
| 2023 | 77.06 | 36,82 |
| 2022 | 68.94 | 25,97 |
| 2021 | 28.42 | 43,77 |
| 2020 | 19.67 | 57,22 |
| 2019 | 19.93 | 59,11 |
| 2018 | 20.41 | 58,67 |
| 2017 | 19.19 | 56,28 |
| 2016 | 16.29 | 52,92 |
| 2015 | 14.17 | 45,79 |
| 2014 | 13.79 | 57,12 |
| 2013 | 13.55 | 59,48 |
| 2012 | 13.6 | 59,12 |
| 2011 | 16 | 59,13 |
| 2010 | 16.96 | 63,80 |
| 2009 | 15.1 | 67,15 |
| 2008 | 14.96 | 65,57 |
| 2007 | 15.43 | 67,34 |
| 2006 | 11.56 | 68,34 |
| 2005 | 10.23 | 66,76 |
Vita 34 Revenue, EBIT, Net Income DE000A0BL849 · A0BL84
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Vita 34, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Vita 34 from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Vita 34’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Vita 34. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Vita 34’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Vita 34’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Vita 34’s growth potential.
Vita 34 Revenue, EBIT and net profit per share
| Date | Vita 34 Revenue | Vita 34 EBIT | Vita 34 Net Income |
|---|---|---|---|
| 2027e | 128.03 M undefined | 921,464.26 undefined | 0 undefined |
| 2026e | 86.76 M undefined | 1.72 M undefined | 712,655.96 undefined |
| 2025e | 84.23 M undefined | 202,000 undefined | -356,327.98 undefined |
| 2024e | 81.81 M undefined | -606,000 undefined | -1.43 M undefined |
| 2023 | 77.06 M undefined | -2.99 M undefined | -1.87 M undefined |
| 2022 | 68.94 M undefined | -12.11 M undefined | -27.09 M undefined |
| 2021 | 28.42 M undefined | -3.07 M undefined | -3.67 M undefined |
| 2020 | 19.67 M undefined | 1.97 M undefined | 1.45 M undefined |
| 2019 | 19.93 M undefined | 2.45 M undefined | 742,000 undefined |
| 2018 | 20.41 M undefined | 2.63 M undefined | 828,000 undefined |
| 2017 | 19.19 M undefined | 141,000 undefined | -323,000 undefined |
| 2016 | 16.29 M undefined | 780,000 undefined | 408,000 undefined |
| 2015 | 14.17 M undefined | -1.5 M undefined | 1.98 M undefined |
| 2014 | 13.79 M undefined | 1.69 M undefined | 1.1 M undefined |
| 2013 | 13.55 M undefined | 1.47 M undefined | 840,000 undefined |
| 2012 | 13.6 M undefined | -740,000 undefined | -580,000 undefined |
| 2011 | 16 M undefined | -340,000 undefined | 1.26 M undefined |
| 2010 | 16.96 M undefined | 740,000 undefined | 480,000 undefined |
| 2009 | 15.1 M undefined | 160,000 undefined | 600,000 undefined |
| 2008 | 14.96 M undefined | -2.27 M undefined | -1.71 M undefined |
| 2007 | 15.43 M undefined | -830,000 undefined | -1.19 M undefined |
| 2006 | 11.56 M undefined | 500,000 undefined | -2.87 M undefined |
| 2005 | 10.23 M undefined | 1.19 M undefined | -1.92 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 10.23 M EUR | 1.19 M EUR | -1.92 M EUR |
| 2006 | 11.56 M EUR | 500,000 EUR | -2.87 M EUR |
| 2007 | 15.43 M EUR | -830,000 EUR | -1.19 M EUR |
| 2008 | 14.96 M EUR | -2.27 M EUR | -1.71 M EUR |
| 2009 | 15.1 M EUR | 160,000 EUR | 600,000 EUR |
| 2010 | 16.96 M EUR | 740,000 EUR | 480,000 EUR |
| 2011 | 16 M EUR | -340,000 EUR | 1.26 M EUR |
| 2012 | 13.6 M EUR | -740,000 EUR | -580,000 EUR |
| 2013 | 13.55 M EUR | 1.47 M EUR | 840,000 EUR |
| 2014 | 13.79 M EUR | 1.69 M EUR | 1.1 M EUR |
| 2015 | 14.17 M EUR | -1.5 M EUR | 1.98 M EUR |
| 2016 | 16.29 M EUR | 780,000 EUR | 408,000 EUR |
| 2017 | 19.19 M EUR | 141,000 EUR | -323,000 EUR |
| 2018 | 20.41 M EUR | 2.63 M EUR | 828,000 EUR |
| 2019 | 19.93 M EUR | 2.45 M EUR | 742,000 EUR |
| 2020 | 19.67 M EUR | 1.97 M EUR | 1.45 M EUR |
| 2021 | 28.42 M EUR | -3.07 M EUR | -3.67 M EUR |
| 2022 | 68.94 M EUR | -12.11 M EUR | -27.09 M EUR |
| 2023 | 77.06 M EUR | -2.99 M EUR | -1.87 M EUR |
| 2024e | 81.81 M EUR | -606,000 EUR | -1.43 M EUR |
| 2025e | 84.23 M EUR | 202,000 EUR | -356,327.98 EUR |
| 2026e | 86.76 M EUR | 1.72 M EUR | 712,655.96 EUR |
| 2027e | 128.03 M EUR | 921,464.26 EUR | 0 EUR |
Vita 34 stock margins DE000A0BL849 · A0BL84
The Vita 34 margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vita 34. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vita 34.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Vita 34's sales revenue. A higher gross margin percentage indicates that the Vita 34 retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Vita 34's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Vita 34's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Vita 34's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Vita 34. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Vita 34's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Vita 34 Margin History
| Vita 34 Gross margin | Vita 34 Profit margin | Vita 34 EBIT margin | Vita 34 Profit margin |
|---|---|---|---|
| 2027e | 36.82 % | 0.72 % | 0 % |
| 2026e | 36.82 % | 1.98 % | 0.82 % |
| 2025e | 36.82 % | 0.24 % | -0.42 % |
| 2024e | 36.82 % | -0.74 % | -1.74 % |
| 2023 | 36.82 % | -3.88 % | -2.42 % |
| 2022 | 25.97 % | -17.57 % | -39.29 % |
| 2021 | 43.77 % | -10.81 % | -12.9 % |
| 2020 | 57.22 % | 10.03 % | 7.37 % |
| 2019 | 59.11 % | 12.31 % | 3.72 % |
| 2018 | 58.67 % | 12.89 % | 4.06 % |
| 2017 | 56.28 % | 0.73 % | -1.68 % |
| 2016 | 52.92 % | 4.79 % | 2.5 % |
| 2015 | 45.79 % | -10.57 % | 13.97 % |
| 2014 | 57.12 % | 12.26 % | 7.98 % |
| 2013 | 59.48 % | 10.85 % | 6.2 % |
| 2012 | 59.12 % | -5.44 % | -4.26 % |
| 2011 | 59.13 % | -2.13 % | 7.88 % |
| 2010 | 63.8 % | 4.36 % | 2.83 % |
| 2009 | 67.15 % | 1.06 % | 3.97 % |
| 2008 | 65.57 % | -15.17 % | -11.43 % |
| 2007 | 67.34 % | -5.38 % | -7.71 % |
| 2006 | 68.34 % | 4.33 % | -24.83 % |
| 2005 | 66.76 % | 11.63 % | -18.77 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 66.76 % | 11.63 % | -18.77 % |
| 2006 | 68.34 % | 4.33 % | -24.83 % |
| 2007 | 67.34 % | -5.38 % | -7.71 % |
| 2008 | 65.57 % | -15.17 % | -11.43 % |
| 2009 | 67.15 % | 1.06 % | 3.97 % |
| 2010 | 63.8 % | 4.36 % | 2.83 % |
| 2011 | 59.13 % | -2.13 % | 7.88 % |
| 2012 | 59.12 % | -5.44 % | -4.26 % |
| 2013 | 59.48 % | 10.85 % | 6.2 % |
| 2014 | 57.12 % | 12.26 % | 7.98 % |
| 2015 | 45.79 % | -10.57 % | 13.97 % |
| 2016 | 52.92 % | 4.79 % | 2.5 % |
| 2017 | 56.28 % | 0.73 % | -1.68 % |
| 2018 | 58.67 % | 12.89 % | 4.06 % |
| 2019 | 59.11 % | 12.31 % | 3.72 % |
| 2020 | 57.22 % | 10.03 % | 7.37 % |
| 2021 | 43.77 % | -10.81 % | -12.9 % |
| 2022 | 25.97 % | -17.57 % | -39.29 % |
| 2023 | 36.82 % | -3.88 % | -2.42 % |
| 2024e | 36.82 % | -0.74 % | -1.74 % |
| 2025e | 36.82 % | 0.24 % | -0.42 % |
| 2026e | 36.82 % | 1.98 % | 0.82 % |
| 2027e | 36.82 % | 0.72 % | 0 % |
Vita 34 Aktienanalyse
What does Vita 34 do?
Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Vita 34's Sales Figures
The sales figures of Vita 34 originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Vita 34’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Vita 34's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Vita 34’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Vita 34 stock
How much was the turnover of the company Vita 34 compared to the previous year?
The revenue of Vita 34 has increased by 6.16% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Vita 34?
The revenue of Vita 34 is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Vita 34 measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Vita 34 so important for investors?
The revenue of Vita 34 is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Vita 34 pay?
Over the past 12 months, Vita 34 paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 3.88 %. For the coming 12 months, Vita 34 is expected to pay a dividend of -0.02 EUR.
What is the dividend yield of Vita 34?
The current dividend yield of Vita 34 is 3.88 %.
When does Vita 34 pay dividends?
Vita 34 pays a quarterly dividend. This is distributed in the months of September, July, June, July.
How secure is the dividend of Vita 34?
Vita 34 paid dividends every year for the past 0 years.
What is the dividend of Vita 34?
For the upcoming 12 months, dividends amounting to -0.02 EUR are expected. This corresponds to a dividend yield of -0.44 %.
In which sector is Vita 34 located?
Vita 34 is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vita 34 from 6/7/2019 amounting to 0.16 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2019.
When did Vita 34 pay the last dividend?
The last dividend was paid out on 6/7/2019.
What was the dividend of Vita 34 in the year 2023?
In the year 2023, Vita 34 distributed 0 EUR as dividends.
In which currency does Vita 34 pay out the dividend?
The dividends of Vita 34 are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Vita 34 stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Vita 34
Our stock analysis for Vita 34 Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vita 34 Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
